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Introduction
Development of new cytotoxic drugs is essential since the 
emerging resistance by cancer cells towards existing drugs. 
Medicinal plants are an ideal target for the discovery of potential 
bioactive compounds or lead structures for new cytotoxic drugs. 
Novel antitumor agents such as paclitaxel (Taxol) (Wani et al., 
1971; Bills et al., 2002), vincristine and vinblastine (Hamburger et 
al., 1991; Tyler, 1986) were reported from plant sources.
The genus Luvunga (Rutaceae) is comprised by only about 
twelve species. Luvunga scandens (Roxb.) Buch-Ham ex Wight & 
Arn is mainly distributed in tropical and humid environments 
throughout China, Cambodia, India, Laos, Indonesia, 
Philippines, Malaysia, Myanmar, Thailand and Vietnam. This 
plant is used for the treatment of several ailments by traditional 
folk medicine. A decoction of the stem of L. scandens is orally 
administered to treat malaria and fatigue (Eswani et al., 2010; 
Ong et al., 2011). A few reports of the phytochemical (Chopra, 
2006), antifungal and insecticidal activity of L. scandens have 
been documented (Singh and Maurya, 2005; Garg and Jain, 1999). 
The present study was aimed to isolate and elucidate the 
structure of two compounds from the dichloromethane extract 
of the stem of Luvunga scandens by spectroscopic techniques, 
and the evaluation of their cytotoxicity.
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A B S T R A C T
Two tirucallane triterpenes, namely flindissol (1) and 3-oxotirucalla-7,24-dien-21-oic-acid 
(2), were isolated from the dichloromethane extract of the stem of Luvunga scandens (Roxb.) 
Buch-Ham ex Wight & Arn, Rutaceae. This is the first report of their isolation from this 
plant. Their structures were constructed by high resolution mass and 2D NMR spectroscopic 
data. The cytotoxic potential of the two pure compounds 1 and 2 were determined by MTT 
assay against human breast adenocarcinoma cell line (MCF-7). Compounds 1 and 2 showed 
potent cytotoxicity against MCF-7 cell line with IC50 values of 13.8 μM and 27.5 μM, respec-
tively. This result suggested their potential activity as antitumor agents. 
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Materials and methods
General experimental procedures
The NMR spectra were recorded on a Bruker 400 MHz NMR 
Spectrometer using CDCl3. The HRMS spectra were recorded 
using a Thermo LTQ-FT mass spectrometer (RMS 2 ppm 
with external calibration) in the Mark Wainwright Analytical 
Centre at The University of New South Wales, Sydney, 
Australia. IR spectra were measured on a Perkin Elmer 
infrared spectrophotometer. The UV spectra were obtained 
on a Shimadzu UV-1800 UV/VIS spectrophotometer. Column 
chromatography was performed on silica gel (70-230 and 230-
400 mesh, Merck, Germany) and Sephadex LH-20 (40-70μm, GE 
healthcare). Organic solvents and TLC plates were purchased 
from Merck, Germany.
Dulbecco’s modified Eagle medium (DMEM), Fetal Bovine Serum 
(FBS), Penicillin-Streptomycin and TripLE Express were purchased 
from GIBCO. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was purchased from Invitrogen (USA). Doxorubicine 
hydrochloride was obtained from Sigma Aldrich (USA).
Plant material
The stems of Luvunga scandens (Roxb) Buch-Ham ex Wight & 
Arn, Rutaceae, were collected from Bukit Pelindung, Kuantan, 
Pahang, Malaysia, in September 2012. Samples were further 
identified by Dr. Shamsul Khamis at Institute of Bioscience, 
Universiti Putra Malaysia. A voucher specimen (No. PIIU 0204) 
was deposited in the Herbarium of the Faculty of Pharmacy, 
International Islamic University Malaysia.
Extraction and isolation
The dried and powdered stem (730 g) of L. scandens was extracted 
by maceration using n-hexane, dichloromethane (DCM) and 
methanol (MeOH) as solvents. The concentrated DCM extract 
(133 g) was successively partitioned by n-hexane (1.8 l), n-hexane 
- DCM (1:1, 1.2 l), DCM (1.2 l), DCM-MeOH (1:1, 1.5 l), and MeOH 
(600 ml). The DCM-MeOH (1:1) fraction (67 g) was subjected to 
column chromatography (CC) for fractionation over silica gel 
(70-230 mesh) with a mobile phase of DCM-EtOAc (100 ml of 
each) of 100:0, 90:10, 80:20, 70:30, 60:40, 50:50 and 0:100 (v/v); and 
finally by EtOAc-MeOH (50:50). The fractions with similar TLC 
profile were combined to yield four fractions. Fraction 2 (62.2 g) 
was further extracted using the above-mentioned method to 
obtain compound 1 (32 mg) and 2 (17 mg).
Flindissol (1) 
White amorphous powder; m.p. 184-187°C; UV (MeOH) Omax: 211 
nm; IR (KBr) Xmax: 3395, 2950, 2372, 1717, 1446, 979 cm
-1; ESI-MS: 
[M + Na]+ m/z 479.3482 (calculated for C30H48O3Na, 479.3496); 
1H 
NMR (400 MHz, CDCl3): G 0.80 (3H, s, CH3-18), 0.93 (
3H, s, CH3-19), 
0.93 (3H, s, CH3-29), 0.95 (
3H, s, CH3-28), 0.99 (
3H, s, CH3-30), 1.71 
(3H, s, CH3-27), 1.73 (
3H, s, CH3-26), 3.49 (
1H, bs, H-3), 4.71 (1H, m, 
H-23), 5.17 (1H, bs, OH-21), 5.19 (1H, d, J = 8.0 Hz, H-24), 5.27 (1H, 
bs, H-7). 13C NMR (100 MHz, CDCl3): G 13.3 (C-19), 17.4 (C-11), 18.4 
(C-27), 21.6 (C-29), 22.6 (C-18), 23.8 (C-6), 26.0 (C-26), 26.8 (C-28), 
28.4 (C-30), 28.7 (C-2), 28.7 (C-16), 31.9 (C-12), 34.1 (C-15), 34.1 
(C-22), 34.5 (C-10), 37.0 (C-4), 40.3 (C-1), 44.2 (C-13), 45.2 (C-17), 
50.0 (C-20), 50.9 (C-9), 51.3 (C-14), 52.0 (C-5), 73.1 (C-23), 75.8 (C-3), 
99.7 (C-21), 118.4 (C-7), 124.5 (C-24), 137.6 (C-25), 146.2 (C-8).
3-Oxotirucalla-7,24-dien-21-oic acid (2)
White amorphous powder; m.p. 238-241°C; UV (MeOH) Omax: 204 
nm; IR (KBr) Xmax: 3754, 3396, 2960, 1710, 1202 cm
-1; ESI-MS: [M + 
H]+ m/z 455.3510 (calculated for C30H47O3, 455.3520); 
1H NMR (400 
MHz, CDCl3): G 0.92 (
3H, s, CH3-18), 1.00 (
3H, s, CH3-19), 1.03 (
3H, s, 
CH3-30), 1.07 (
3H, s, CH3-28), 1.13 (
3H, s, CH3-29), 1.50 (
1H, m, H-1), 
1.50 (2H, m, H-11), 1.61 (3H, s, CH3-26), 1.70 (
3H, s, CH3-27), 1.77 (
1H, 
m, H-5), 1.99 (1H, m, H-1), 1.99 (2H, m, H-23), 2.11 (2H, m, H-6), 2.11 
(1H, m, H-17), 2.29 (1H, m, Heq-2), 2.29 (1H, m, H-9), 2.29 (1H, m, 
H-20), 2.75 (1H, ddd, J = 8.4, 8.4, 4.8 Hz, Hax-2), 5.11 (1H, bt, H-24), 
5.34 (1H, bs, H-7). 13C NMR (100 MHz, CDCl3): G 12.7 (C-19), 17.7 
(C-26), 17.9 (C-11), 21.6 (C-18), 21.7 (C-29), 24.4 (C-6), 24.5 (C-28), 
25.7 (C-27), 26.0 (C-23), 27.2 (C-16), 27.4 (C-30), 30.0 (C-12), 32.3 
(C-22), 33.5 (C-15), 34.9 (C-2), 35.1 (C-10), 38.6 (C-1), 43.3 (C-13), 47.3 
(C-20), 47.9 (C-4), 48.2 (C-9), 49.8 (C-17), 51.0 (C-14), 52.4 (C-5), 118.2 
(C-7), 123.5 (C-24), 132.4 (C-25), 145.5 (C-8), 181.9 (C-21), 217.1 (C-3).
In vitro cytotoxicity assay
The cytotoxic activity of the isolated compounds against MCF-7 
cells was measured by MTT assay according to Mosmann (1983) 
with some modifications. A total of 2 × 105 cells/ml were plated 
in a 96-well plate overnight; then, the cells were treated in 
triplicate with various concentrations of the compounds. After 
24 h of incubation, the cells were washed with phosphate buffer 
saline (PBS) and assayed by addition of 30 μl of MTT solution 
(5 mg/ml MTT in PBS). After 4 h of incubation, the formazan 
crystals were dissolved in 120 μl DMSO and left in the dark 
at room temperature for an additional 1 h. The absorbance 
measured at 570 nm and 630 nm used as reference wavelength 
was performed using a microplate reader (TECAN infinite M200). 
The wells with untreated cells were taken as the control, wells 
with medium with 0.5% (v/v) of EtOH were used as solvent 
control and wells with Doxorubicin were used as positive 
control. Results were expressed as a percentage of the average 
absorbance of sample treated cells with respect to untreated 
ones. The half maximal inhibitory concentration (IC50) was 
defined as the concentration of compound that caused a 50% 
reduction in cell viability against MCF-7 cell line. Viability of cells 
(%) was calculated using the following equation: 
Viability of cells (%) = [(ASample-ABlank)/(AUntreated-ABlank)] × 100
Results and discussion
Compound 1 was obtained as a white amorphous powder. 
The 1H-NMR and 13C-NMR data together with the DEPT 
135 spectrum proved the presence of 30 C-atom signals 
corresponding to seven Me, eight sp3 CH2, seven sp
3 CH, two 
sp2 CH groups, and four sp3 and two sp2 quaternary C-atoms. 
Accurate mass measurements of compound 1 obtained by 
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ESI-MS yielded a parent mass at m/z 479.3482 in positive 
ionization mode which, in conjunction with the data of 
other spectra, suggested the sodium adduct [M + Na]+ of a 
compound with a molecular formula of C30H48O3 (calculated 
mass 479.3496, [C30H48O3 + Na]
+), accounting for 7 degrees of 
unsaturation. The 1H-NMR and 13C-NMR data of compound 1 
were identical to those of the tirucallane triterpene flindissol, 
which has the unusual 3-D configuration of the A-ring hydroxyl 
group (Birch et al., 1963) and has been previously isolated from 
several species of the Rutaceae family (Guang-Yi et al., 1988; 
Bevan et al., 1967; Waterman, 1973). This is the first report of 
flindissol found in L. scandens.
 
by the ESI-MS mass spectrum with [M + H]+ at m/z 455.3510 
for 2, which suggested the molecular formula C30H46O3 (calcd 
mass 455.3520, [C30H46O3 + H]
+), accounting for 8 degrees of 
unsaturation. Accordingly, compound 2 was established as 
3-oxotirucalla-7,24-dien-21-oic acid, a tirucallane triterpene 
first isolated from oleoresin of Aucoumea klaineana (Tessier 
et al., 1982) and later identified in Xanthoceras sorbifolia 
(Ma et al., 2000), Rhus javainica L. (Lee et al., 2005), Pancovia 
pedicellaris (Soh et al., 2009), and Feroniella lucida (Sriyatep et 
al., 2014), which displays inhibitory activity against HIV-1 
protease (Ma et al., 2000; Nimmanpipug et al., 2009) and 
cytotoxicity (Lee et al., 2005). 
Compounds 1 and 2 were assayed for their dose-response 
effect on the viability of human breast adenocarcinoma cell 
line (MCF-7) by MTT assay. Doxorubicin was used as positive 
control to compare the cytotoxicity of the pure 1 and 2. In 
order to determine the growth inhibition, the MCF-7 cells were 
incubated with various concentrations of the compounds 
for 24 h. The inhibition concentration required reduction of 
50% of cell viability (IC50) was determined by comparison to 
the untreated control. Based on the results of the MTT assay 
(Table 1), both compounds isolated from stems of L. scandens 
inhibited the growth of human breast adenocarcinoma 
cells. A bar chart of the percentage of viability of cells was 
plotted against sample concentrations (Fig. 1). Compound 1 
was comparatively more cytotoxic at a lower IC50 value (13.8 
μM) than that of compound 2 (27.5 μM), and less than that 
of doxorubicin.
Components KI
1 13.8
2 27.5
Doxorubicin 6.21
Table 1
Cytotoxicity data (IC50 value in μM) of compounds 1 and 2 
against MCF-7 cell line.
Figure 1 – Cytotoxic activity of compounds 1-2 against MCF-
7 cell line. Untreated cells and Doxorubicin were used as 
negative and positive control respectively. The error bars 
indicate mean standard error of triplicate values. Asterisks 
represent statistically significant (p < 0.05) data compared to 
controls (untreated cells).
The NMR spectra of compound 2 were similar to those of 1, 
with exception to the additional one sp3 and two sp2 quaternary 
C-atoms and lack of three sp3 CH. The three sp3 CH signals 
(GC 75.8, 99.7 and 73.1) of compound 1 were bound to oxygen at 
C-3, C-21 and C-23, and their absence in compound 2 indicated 
a change in the 3-hydroxy substituent and a modification of 
the side-chain lactol. The appearance of two additional sp2 
quaternary C-atoms in 2 suggests the presence of COOH 
(GC 181.9) and C=O (GC 217.1) moieties, which affirm the 
suggested structural modifications. In the 1H NMR spectrum, 
the presence of a 3-oxo moiety was confirmed by the coupling 
pattern ddd at GH 2.75 for the H-2 axial proton. This was further 
confirmed by tracing of cross peaks between the neighboring 
coupled protons at G 2.75 (Hax-2) and 1.99 and 1.50 (H-1, both m) 
in the COSY spectrum. Two olefinic proton signals, appeared 
at G 5.34 (H-7, bs) and 5.11 (H-24, bt), correlated in the HSQC 
spectrum (showing one-bond C-H correlations) to carbons at 
G 118.2 (C-7) and 123.5 (C-24), respectively. 
Comparison of 13C-NMR data of 2 with 3 D-hydroxy-
tirucalla-7,24-dien-21-oic acid (D-elemolic acid) (3) (Guang-Yi 
et al., 1988; Tessier et al., 1982; Cotterrell et al., 1970) showed 
good agreement except for a keto group at C-3 (GC 217.1) 
in 2, instead of a secondary alcohol group (GC 74.2) in 3. 
These observations suggest that 2 differed from 3 only in 
oxidation of the 3 D-hydroxyl function to the corresponding 
3-oxo. A comparison of 13C-NMR data with those reported 
for 3-oxotirucalla-7,24-dien-21-oic acid at 75 MHz (Ma, et al., 
2000) showed identical signals. This was further evidenced 
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Conclusions
It is concluded from spectroscopic evidence that two 
tirucallane triterpenes were isolated from the dichloromethane 
extract of the stems of Luvunga scandens. The tirucallane 
triterpenes flindissol (1) and 3-oxotirucalla-7,24-dien-21-oic 
acid (2) were isolated for the first time from this plant. The 
cytotoxicity of compounds 1 and 2, as determined by MTT 
assay against MCF-7 cell line, are consistent with the findings 
that medicinal plants are an ideal source of cytotoxic agents, 
thus, subsequent research towards the discovery of more 
cytotoxic agents should continue. 
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